Theme “Pragmatic trials: academic, regulatory, and industry perspective”.
Whereas the traditional randomized controlled trial is designed to establish efficacy of a specific drug, i.e. the effect under ideal conditions, the pragmatic trial is designed to establish effectiveness, i.e. how well the drug works in everyday clinical practice. To present the topic from different angles, we have invited speakers from regulatory agencies, academia, and the industry including Mira G.P. Zuidgeest and Simon Skibsted.
Please sign up by sending an email to info@dsfe.dk, no later than October 20th. We hope as many of you as possible are able to participate and we are looking forward to see you!